Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial

BACKGROUND: Chronic spontaneous urticaria (CSU) is characterized by the spontaneous appearance of wheals, angioedema, or both for > 6 weeks. Continuous treatment with H1-antihistamines is used as a first-line treatment for CSU. However, H1-antihistamine treatment leads to absence of symptoms in l...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukunaga, Atsushi, Oda, Yoshiko, Washio, Ken, Omori, Takashi, Kakei, Yasumasa, Hide, Michihiro, Nishigori, Chikako
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945582/
https://www.ncbi.nlm.nih.gov/pubmed/31906999
http://dx.doi.org/10.1186/s13063-019-3878-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945582/
https://www.ncbi.nlm.nih.gov/pubmed/31906999
http://dx.doi.org/10.1186/s13063-019-3878-2

Ejemplares similares